IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v358y2024ics027795362400710x.html
   My bibliography  Save this article

‘Managing values’ in health economics modelling: Philosophical and practical considerations

Author

Listed:
  • Harvard, Stephanie
  • Winsberg, Eric B.

Abstract

Stakeholder involvement has been proposed as a key strategy for appropriately managing value-laden decisions or ‘value judgments’ in health economics modelling. Philosophers of science, however, conceive of stakeholder involvement in research in conflicting ways, and also propose alternative strategies for ‘managing values’ in science. Furthermore, all proposed strategies for managing values in science raise philosophical questions and practical challenges that are difficult to resolve. As a result, health economists who seek to appropriately inform value judgments in modelling must currently go without straightforward guidance. There is a need to further explore how health economists should manage value judgments in modelling, taking into account philosophical debates and contextual constraints. This paper discusses core proposals for managing values in science and identifies philosophical questions and practical challenges these proposals leave unresolved. It further considers how this could potentially inform processes to manage value judgments in health economics modelling, using examples from an ongoing modelling project called LEAP (Lifetime Exposures and Asthma Outcomes Projection). We conclude that all strategies to ‘manage values’ in health economics modelling have strengths and weaknesses, but are generally compatible with one another, suggesting that health economists may use a combination of strategies. Further research is needed to explore the effects of strategies to ‘manage values’ in health economics modelling.

Suggested Citation

  • Harvard, Stephanie & Winsberg, Eric B., 2024. "‘Managing values’ in health economics modelling: Philosophical and practical considerations," Social Science & Medicine, Elsevier, vol. 358(C).
    • Handle: RePEc:eee:socmed:v:358:y:2024:i:c:s027795362400710x
    DOI: 10.1016/j.socscimed.2024.117256
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S027795362400710X
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.socscimed.2024.117256?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Benjamin M. Sanderson & Rosie A. Fisher, 2020. "A fiery wake-up call for climate science," Nature Climate Change, Nature, vol. 10(3), pages 175-177, March.
    2. Stephanie Harvard, 2024. "Making Decision Models Fit for Purpose: The Importance of Ensuring Stakeholder Involvement," PharmacoEconomics, Springer, vol. 42(3), pages 249-252, March.
    3. Stephanie Harvard & Amin Adibi & Adam Easterbrook & Gregory R. Werker & David Murphy & Don Grant & Alison Mclean & Zhina Majdzadeh & Mohsen Sadatsafavi, 2022. "Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network," PharmacoEconomics, Springer, vol. 40(10), pages 1005-1009, October.
    4. Seamus Kent & Frauke Becker & Talitha Feenstra & An Tran-Duy & Iryna Schlackow & Michelle Tew & Ping Zhang & Wen Ye & Shi Lizheng & William Herman & Phil McEwan & Wendelin Schramm & Alastair Gray & Jo, 2019. "The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood," PharmacoEconomics, Springer, vol. 37(11), pages 1305-1312, November.
    5. David M. Eddy & William Hollingworth & J. Jaime Caro & Joel Tsevat & Kathryn M. McDonald & John B. Wong, 2012. "Model Transparency and Validation," Medical Decision Making, , vol. 32(5), pages 733-743, September.
    6. Harvard, Stephanie & Werker, Gregory R. & Silva, Diego S., 2020. "Social, ethical, and other value judgments in health economics modelling," Social Science & Medicine, Elsevier, vol. 253(C).
    7. N. K. Gibbs & C. Angus & S. Dixon & C. D. H. Parry & P. S. Meier, 2023. "Stakeholder Engagement in the Development of Public Health Economic Models: An Application to Modelling of Minimum Unit Pricing of Alcohol in South Africa," Applied Health Economics and Health Policy, Springer, vol. 21(3), pages 395-403, May.
    8. Harvard, Stephanie & Winsberg, Eric & Symons, John & Adibi, Amin, 2021. "Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling," Social Science & Medicine, Elsevier, vol. 286(C).
    9. Drummond, Michael F. & Sculpher, Mark J. & Claxton, Karl & Stoddart, Greg L. & Torrance, George W., 2015. "Methods for the Economic Evaluation of Health Care Programmes," OUP Catalogue, Oxford University Press, edition 4, number 9780199665884, Decembrie.
    10. Stephanie Harvard & Eric Winsberg, 2023. "Patient and Public Involvement in Health Economics Modelling Raises the Need for Normative Guidance," PharmacoEconomics, Springer, vol. 41(7), pages 733-740, July.
    11. Jaclyn Beca & Don Husereau & Kelvin K. W. Chan & Neil Hawkins & Jeffrey S. Hoch, 2018. "Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment," PharmacoEconomics, Springer, vol. 36(1), pages 7-15, January.
    12. Alan Shiell & Penelope Hawe & Janelle Seymour, 1997. "Values and preferences are not necessarily the same," Health Economics, John Wiley & Sons, Ltd., vol. 6(5), pages 515-518, September.
    13. Christopher James Sampson & Renée Arnold & Stirling Bryan & Philip Clarke & Sean Ekins & Anthony Hatswell & Neil Hawkins & Sue Langham & Deborah Marshall & Mohsen Sadatsafavi & Will Sullivan & Edward , 2019. "Transparency in Decision Modelling: What, Why, Who and How?," PharmacoEconomics, Springer, vol. 37(11), pages 1355-1369, November.
    14. Mary Bunka & Shahzad Ghanbarian & Linda Riches & Ginny Landry & Louisa Edwards & Alison M. Hoens & Stirling Bryan, 2022. "Collaborating with Patient Partners to Model Clinical Care Pathways in Major Depressive Disorder: The Benefits of Mixing Evidence and Lived Experience," PharmacoEconomics, Springer, vol. 40(10), pages 971-977, October.
    15. Stephanie Harvard & Gregory R. Werker, 2021. "Health Economists on Involving Patients in Modeling: Potential Benefits, Harms, and Variables of Interest," PharmacoEconomics, Springer, vol. 39(7), pages 823-833, July.
    16. Richard Z. Xie & Erica deFur Malik & Mark T. Linthicum & Jennifer L. Bright, 2021. "Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States," PharmacoEconomics, Springer, vol. 39(6), pages 631-638, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Harvard, Stephanie & Winsberg, Eric & Symons, John & Adibi, Amin, 2021. "Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling," Social Science & Medicine, Elsevier, vol. 286(C).
    2. Andrew J. Palmer & Julie A. Campbell & Barbara de Graaff & Nancy Devlin & Hasnat Ahmad & Philip M Clarke & Mingsheng Chen & Lei Si, 2021. "Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia," Health Economics, John Wiley & Sons, Ltd., vol. 30(8), pages 1950-1977, August.
    3. Harvard, Stephanie & Werker, Gregory R. & Silva, Diego S., 2020. "Social, ethical, and other value judgments in health economics modelling," Social Science & Medicine, Elsevier, vol. 253(C).
    4. Svenn Alexander Hansen & Eline Aas & Oddvar Solli, 2020. "A cost-utility analysis of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 73-84, February.
    5. Irina Pokhilenko & Luca M. M. Janssen & Aggie T. G. Paulus & Ruben M. W. A. Drost & William Hollingworth & Joanna C. Thorn & Sian Noble & Judit Simon & Claudia Fischer & Susanne Mayer & Luis Salvador-, 2023. "Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUM," Applied Health Economics and Health Policy, Springer, vol. 21(2), pages 155-166, March.
    6. Chiranjeev Sanyal & Don Husereau, 2020. "Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists," Applied Health Economics and Health Policy, Springer, vol. 18(3), pages 375-392, June.
    7. Yesim Tozan & Joshua Kiyingi & Sooyoung Kim & Flavia Namuwonge & Florence Namuli & Vicent Ssentumbwe & Rashida Namirembe & Edwinnah Kasidi & Ozge Sensoy Bahar & Mary M Mckay & Fred M Ssewamala, 2024. "Micro-costing analysis of a combination intervention for improved mental health and HIV risk behaviors among school-going adolescent girls in Uganda," PLOS Mental Health, Public Library of Science, vol. 1(7), pages 1-14, December.
    8. Dong-Won Kang & Patricio B. Lynn & Li Wang & Shouhao Zhou & Chan Shen, 2025. "Cost-Effectiveness of Fruquintinib for Refractory Metastatic Colorectal Cancer in the USA," PharmacoEconomics - Open, Springer, vol. 9(1), pages 93-101, January.
    9. Andrew J. Mirelman & Miqdad Asaria & Bryony Dawkins & Susan Griffin & Richard Cookson & Peter Berman, 2020. "Fairer Decisions, Better Health for All: Health Equity and Cost-Effectiveness Analysis," World Scientific Book Chapters, in: Paul Revill & Marc Suhrcke & Rodrigo Moreno-Serra & Mark Sculpher (ed.), Global Health Economics Shaping Health Policy in Low- and Middle-Income Countries, chapter 4, pages 99-132, World Scientific Publishing Co. Pte. Ltd..
    10. Valentina Prevolnik Rupel & Marko Ogorevc, 2023. "EQ-5D-5L Value Set for Slovenia," PharmacoEconomics, Springer, vol. 41(11), pages 1515-1524, November.
    11. Julie A. Campbell & Glen J. Henson & Valery Fuh Ngwa & Hasnat Ahmad & Bruce V. Taylor & Ingrid Mei & Andrew J. Palmer, 2025. "Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modif," PharmacoEconomics, Springer, vol. 43(2), pages 223-239, February.
    12. Christopher M Doran & Irina Kinchin, 2020. "Economic and epidemiological impact of youth suicide in countries with the highest human development index," PLOS ONE, Public Library of Science, vol. 15(5), pages 1-11, May.
    13. Mira Johri & Laura J. Damschroder & Brian J. Zikmund‐Fisher & Peter A. Ubel, 2005. "The importance of age in allocating health care resources: does intervention‐type matter?," Health Economics, John Wiley & Sons, Ltd., vol. 14(7), pages 669-678, July.
    14. Boniface Oyugi & Olena Nizalova & Sally Kendall & Stephen Peckham, 2024. "Does a free maternity policy in Kenya work? Impact and cost–benefit consideration based on demographic health survey data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(1), pages 77-89, February.
    15. Dimitris Bertsimas & John Silberholz & Thomas Trikalinos, 2018. "Optimal healthcare decision making under multiple mathematical models: application in prostate cancer screening," Health Care Management Science, Springer, vol. 21(1), pages 105-118, March.
    16. Kaspar Walter Meili & Anna Månsdotter & Linda Richter Sundberg & Jan Hjelte & Lars Lindholm, 2022. "An initiative to develop capability-adjusted life years in Sweden (CALY-SWE): Selecting capabilities with a Delphi panel and developing the questionnaire," PLOS ONE, Public Library of Science, vol. 17(2), pages 1-21, February.
    17. Muchandifunga Trust Muchadeyi & Karla Hernandez-Villafuerte & Gian Luca Tanna & Rachel D. Eckford & Yan Feng & Michela Meregaglia & Tessa Peasgood & Stavros Petrou & Jasper Ubels & Michael Schlander, 2024. "Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations," PharmacoEconomics, Springer, vol. 42(7), pages 767-782, July.
    18. Lili Wang & Lei Si & Fiona Cocker & Andrew J. Palmer & Kristy Sanderson, 2018. "A Systematic Review of Cost-of-Illness Studies of Multimorbidity," Applied Health Economics and Health Policy, Springer, vol. 16(1), pages 15-29, February.
    19. Etienne Nédellec & Judith Pineau & Patrice Prognon & Nicolas Martelli, 2018. "Level of Evidence in Economic Evaluations of Left Atrial Appendage Closure Devices: A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 16(6), pages 793-802, December.
    20. Qi Cao & Erik Buskens & Hans L. Hillege & Tiny Jaarsma & Maarten Postma & Douwe Postmus, 2019. "Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 475-482, April.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:358:y:2024:i:c:s027795362400710x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.